Newbridge Financial Services Group’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17
| Closed | -$91 | – | 1121 |
|
|
2024
Q1 | $91 | Hold |
17
| – | – | ﹤0.01% | 1145 |
|
|
2023
Q4 | $25 | Sell |
17
-98
| -85% | -$144 | ﹤0.01% | 1107 |
|
|
2023
Q3 | $160 | Hold |
115
| – | – | ﹤0.01% | 1242 |
|
|
2023
Q2 | $169 | Hold |
115
| – | – | ﹤0.01% | 1293 |
|
|
2023
Q1 | $190 | Hold |
115
| – | – | ﹤0.01% | 1351 |
|
|
2022
Q4 | $161 | Hold |
115
| – | – | ﹤0.01% | 1391 |
|
|
2022
Q3 | $0 | Sell |
115
-716
| -86% | – | ﹤0.01% | 1399 |
|
|
2022
Q2 | $2K | Hold |
831
| – | – | ﹤0.01% | 1163 |
|
|
2022
Q1 | $2K | Hold |
831
| – | – | ﹤0.01% | 1277 |
|
|
2021
Q4 | $5K | Hold |
831
| – | – | ﹤0.01% | 1060 |
|
|
2021
Q3 | $6K | Buy |
831
+733
| +748% | +$5.29K | ﹤0.01% | 968 |
|
|
2021
Q2 | $1K | Hold |
98
| – | – | ﹤0.01% | 1340 |
|
|
2021
Q1 | $1K | Buy |
+98
| New | +$1K | ﹤0.01% | 1249 |
|